Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Causes and Control

• Publication date

  2013-09-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10552-013-0285-yPMID 24036889PMCID PMC3836434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer

  2013cited by this paper
• Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers

  2013cited by this paper
• Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions.

  2012cited by this paper
• Risk of prostate cancer is not associated with levels of C‐reactive protein and other commonly used markers of inflammation

  2011cited by this paper
• Genetic variation in C‐reactive protein in relation to colon and rectal cancer risk and survival

  2011cited by this paper
• Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.

  2011cited by this paper
• Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study

  2011cited by this paper
• Association of Inflammatory Markers with Colorectal Cancer Incidence in the Atherosclerosis Risk in Communities Study

  2011influential reference
• Mostly Harmless Econometrics: An Empiricist's Companion

  2011cited by this paper
• Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

  2011cited by this paper
• Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesity-associated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985-2004.

  2011cited by this paper
• C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment

  2011cited by this paper
• C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies.

  2011cited by this paper
• Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels

  2011cited by this paper
• Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

  2011cited by this paper
• Impact of repeated measures and sample selection on genome‐wide association studies of fasting glucose

  2010influential reference
• Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies

  2010cited by this paper
• C-reactive protein and risk of lung cancer.

  2010cited by this paper
• Association of a Fasting Glucose Genetic Risk Score With Subclinical Atherosclerosis

  2010cited by this paper
• C-reactive protein and the risk of cancer: a mendelian randomization study.

  2010cited by this paper
• Mostly Harmless Econometrics: An Empiricist's Companion

  2010cited by this paper
• Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population

  2010cited by this paper
• C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

  2009cited by this paper
• Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer

  2009cited by this paper
• Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

  2009cited by this paper
• C-reactive protein and venous thromboembolism

  2009cited by this paper
• Role of traditional and new biomarkers in breast carcinogenesis

  2009cited by this paper
• Circulating prediagnostic interleukin‐6 and C‐reactive protein and prostate cancer incidence and mortality

  2009cited by this paper
• Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

  2009cited by this paper
• Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

  2009cited by this paper
• Proinflammatory cytokines in CRP baseline regulation.

  2009cited by this paper
• Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study

  2009cited by this paper
• Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

  2009cited by this paper
• Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein.

  2008influential reference
• Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.

  2008cited by this paper
• Inflammation and cancer prevention.

  2008cited by this paper
• Celebrating the 25 th Anniversary of Statistics in Medicine Mendelian randomization : Using genes as instruments for making causal inferences in epidemiology

  2008cited by this paper
• SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

  2008cited by this paper
• C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies

  2008cited by this paper
• Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.

  2008influential reference
• A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.

  2007cited by this paper
• Obesity and colorectal cancer risk: a meta-analysis of cohort studies.

  2007cited by this paper
• C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

  2006cited by this paper
• Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction

  2006cited by this paper
• A prospective study of serum C-reactive protein and colorectal cancer risk in men.

  2006cited by this paper
• Recent advances in the relationship between obesity, inflammation, and insulin resistance.

  2006cited by this paper
• Plasma C-Reactive Protein and Risk of Cancer: A Prospective Study from Greece

  2006cited by this paper
• An Introduction to Modern Econometrics Using Stata

  2006cited by this paper
• Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition Cohort

  2005cited by this paper
• Prevention of human cancer by modulation of chronic inflammatory processes.

  2005cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• Is C-reactive protein an inflammation opsonin that signals colon cancer risk?

  2004cited by this paper
• C-reactive protein and risk of colon cancer.

  2004cited by this paper
• Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?

  2004cited by this paper
• At the crossroads of inflammation and cancer.

  2004cited by this paper
• No association between pre‐diagnostic plasma C‐reactive protein concentration and subsequent prostate cancer

  2004cited by this paper
• C-reactive protein and risk of colon cancer.

  2004cited by this paper
• Cancer Causes & Control

  2004cited by this paper
• C-reactive protein and the risk of incident colorectal cancer.

  2004cited by this paper
• Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987.

  2003cited by this paper
• Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared.

  2002cited by this paper
• A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments

  2002cited by this paper
• Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study.

  2002cited by this paper
• Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.

  2001cited by this paper
• Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

  1997cited by this paper
• The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

  1989cited by this paper
• American Journal of Epidemiology Original Contribution Circulating C-reactive Protein Concentrations and Risks of Colon and Rectal Cancer: a Nested Case-control Study within the European Prospective Investigation into Cancer and Nutrition

  year unknowncited by this paper

• Role of COUP-TFII in cardiovascular diseases and colorectal cancer: Insights into the molecular mechanisms and clinical relevance (Review)

  2025cites this paper
• Relationship between oxidative balance score and prostate cancer: a cross-sectional study of NHANES, 1999–2010

  2024cites this paper
• A predictive role of C-reactive protein in colorectal cancer risk: an updated meta-analysis from 780,985 participants and 11,289 cancer cases

  2023cites this paper
• Linking Physical Activity to Breast Cancer via Inflammation, Part 2: The Effect of Inflammation on Breast Cancer Risk

  2023cites this paper
• Biomarkers of glucose homeostasis and inflammation with risk of prostate cancer: A case-cohort study.

  2022cites this paper
• Hypothesized Explanations for the Observed Lung Cancer Survival Benefit Among Hispanics/Latinos in the United States

  2022cites this paper
• Polygenic risk prediction models for colorectal cancer: a systematic review

  2022cites this paper
• Molecular Biology Networks and Key Gene Regulators for Inflammatory Biomarkers Shared by Breast Cancer Development: Multi-Omics Systems Analysis

  2021cites this paper
• A multiethnic bidirectional Mendelian randomization study negates causal effects of C-reactive protein concentrations on lung cancer

  2021cites this paper
• Cardiovascular morbidities in postoperative colorectal cancer patients

  2021cites this paper
• Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study

  2021cites this paper
• Dietary inflammatory index and the risk of non-communicable chronic disease and mortality: an umbrella review of meta-analyses of observational studies

  2021cites this paper
• Genetically determined elevated C-reactive protein associated with primary colorectal cancer risk: Mendelian randomization with lifestyle interactions.

  2021influential citation
• Genetically Predicted C-Reactive Protein Associated With Postmenopausal Breast Cancer Risk: Interrelation With Estrogen and Cancer Molecular Subtypes Using Mendelian Randomization

  2021cites this paper
• Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene–gene and gene–lifestyle interaction

  2021cites this paper
• Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research

  2020cites this paper
• Genetically predicted C-reactive protein associated with breast cancer risk: interrelation with estrogen and cancer molecular subtypes using a Mendelian randomization

  2020cites this paper
• Nutritional genomics, inflammation and obesity

  2020cites this paper
• C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer

  2020cites this paper
• Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies.

  2020cites this paper
• Pro-inflammatory cytokine polymorphisms in ONECUT2 and HNF4A and primary colorectal carcinoma: a post genome-wide gene-lifestyle interaction study.

  2020cites this paper
• High-sensitivity C-reactive protein, hemoglobin A1c and breast cancer risk: a nested case–control study from Alberta’s Tomorrow Project cohort

  2020cites this paper
• The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study

  2019cites this paper
• Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine.

  2019cites this paper
• The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma

  2019cites this paper
• Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study

  2019cites this paper
• Absence of excess body fatness

  2019cites this paper
• Mendelian randomization study of C-reactive protein and cancer risk : the Korean genome and epidemiology study

  2019cites this paper
• Association of IL-8 -251T/A, +781C/T and +396T/G genetic polymorphisms and haplotypes with breast cancer risk in a Northern Chinese population

  2018cites this paper
• Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.

  2018influential citation
• Association of Hospitalization, Critical Illness, and Infection with Brain Structure in Older Adults

  2018cites this paper
• Performance of quantitative immunochemical test for fecal hemoglobin for surveillance of colorectal neoplasia after polypectomy in clinical practice

  2017cites this paper
• Enhancing the Infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for Cancer Epidemiology Research: ARIC Cancer

  2017cites this paper
• Plasma fatty acids and risk of colon and rectal cancers in the Singapore Chinese Health Study

  2017cites this paper
• Role of C-Reactive Protein in Cancer

  2017cites this paper
• Association of IL-8 genetic polymorphisms and breast cancer risk in a Chinese population

  2017cites this paper
• Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women

  2016cites this paper
• Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.

  2016cites this paper
• The George W. Comstock Center for Public Health Research and Prevention: A Century of Collaboration, Innovation, and Translation.

  2016cites this paper
• Increased peri-ductal collagen micro-organization may contribute to raised mammographic density

  2016cites this paper
• Plasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysis

  2015cites this paper
• Circulating C-Reactive Protein and Breast Cancer Risk—Systematic Literature Review and Meta-analysis of Prospective Cohort Studies

  2015cites this paper
• Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality.

  2015cites this paper
• Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.

  2015cites this paper
• Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non‐Hispanic white women: The breast cancer health disparities study

  2015cites this paper
• Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer

  2015cites this paper
• Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies

  2015cites this paper
• Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study

  2015cites this paper
• Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort

  2015cites this paper
• C-reactive protein and risk of breast cancer: A systematic review and meta-analysis

  2015cites this paper
• Understanding the Role of the Immune System in the Development of Cancer: New Opportunities for Population-Based Research

  2015cites this paper
• A Prospective Follow-up Study of the Relationship between C-Reactive Protein and Human Cancer Risk in the Chinese Kailuan Female Cohort

  2014cites this paper
• C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis

  2014cites this paper
• Low-grade inflammation, immune capacity, and cancer

  2014cites this paper
• Sleep Duration and Risk of Lung Cancer in the Physicians' Health Study

  2014cites this paper
• Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India

  2014cites this paper